← All stocks

INOVIO PHARMACEUTICALS, INC.

INO No buying or selling
CIK 0001055726 #4191 in the set updated 18 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

11 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Shea Jacqueline Elizabeth
Chief Executive Officer
111,021
$62.17K
+230.0%
Weiner David B.
Director
87,592
$49.05K
+6.2%
Humeau Laurent
Chief Scientific Officer
46,823
$26.22K
+92.4%
KIES PETER
CFO
42,854
$24.00K
+75.9%
Sumner Michael John
Chief Medical Officer
42,038
$23.54K
+411.5%
BENITO SIMON X
Director
12,191
$6.83K
+21.6%
YARNO WENDY L
Director
10,512
$5.89K
+26.0%
Miller Ann Calby
Director
9,877
$5.53K
+28.1%
Shepard Jay
Director
9,209
$5.16K
+30.8%
DANSEY ROGER D
Director
8,916
$4.99K
+32.1%
Zoth Lota S.
Director
8,726
$4.89K
+33.0%

No percentages here. This company's share count has moved by a factor of 4.0 over the window, from 26,099,991 to 103,397,518 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 25
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 254,748
History held since 4 Jan 2017